vs
Side-by-side financial comparison of GE HealthCare (GEHC) and REINSURANCE GROUP OF AMERICA INC (RGA). Click either name above to swap in a different company.
REINSURANCE GROUP OF AMERICA INC is the larger business by last-quarter revenue ($6.6B vs $5.1B, roughly 1.3× GE HealthCare). GE HealthCare runs the higher net margin — 8.0% vs 7.0%, a 1.0% gap on every dollar of revenue. On growth, REINSURANCE GROUP OF AMERICA INC posted the faster year-over-year revenue change (26.6% vs 7.4%). Over the past eight quarters, GE HealthCare's revenue compounded faster (3.0% CAGR vs 2.3%).
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
Reinsurance Group of America, Incorporated is a holding company for a global life and health reinsurance entity based in Greater St. Louis within the western suburb of Chesterfield, Missouri, United States. With approximately $3.9 trillion of life reinsurance in force and assets of $118.7 billion as of December 31, 2024, RGA has grown to become the only international company to focus primarily on life and health-related reinsurance.
GEHC vs RGA — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.1B | $6.6B |
| Net Profit | $411.0M | $463.0M |
| Gross Margin | 38.5% | — |
| Operating Margin | 10.0% | 7.7% |
| Net Margin | 8.0% | 7.0% |
| Revenue YoY | 7.4% | 26.6% |
| Net Profit YoY | -30.1% | 212.8% |
| EPS (diluted) | $0.85 | $6.91 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $5.1B | — | ||
| Q4 25 | $5.7B | $6.6B | ||
| Q3 25 | $5.1B | $6.2B | ||
| Q2 25 | $5.0B | $5.6B | ||
| Q1 25 | $4.8B | $5.3B | ||
| Q4 24 | $5.3B | $5.2B | ||
| Q3 24 | $4.9B | $5.7B | ||
| Q2 24 | $4.8B | $4.9B |
| Q1 26 | $411.0M | — | ||
| Q4 25 | $588.0M | $463.0M | ||
| Q3 25 | $446.0M | $253.0M | ||
| Q2 25 | $486.0M | $180.0M | ||
| Q1 25 | $564.0M | $286.0M | ||
| Q4 24 | $721.0M | $148.0M | ||
| Q3 24 | $470.0M | $156.0M | ||
| Q2 24 | $428.0M | $203.0M |
| Q1 26 | 38.5% | — | ||
| Q4 25 | 39.7% | — | ||
| Q3 25 | 38.7% | — | ||
| Q2 25 | 39.6% | — | ||
| Q1 25 | 42.1% | — | ||
| Q4 24 | 42.8% | — | ||
| Q3 24 | 41.7% | — | ||
| Q2 24 | 41.4% | — |
| Q1 26 | 10.0% | — | ||
| Q4 25 | 14.5% | 7.7% | ||
| Q3 25 | 12.7% | 5.2% | ||
| Q2 25 | 13.1% | 6.1% | ||
| Q1 25 | 13.2% | 7.0% | ||
| Q4 24 | 15.1% | 4.3% | ||
| Q3 24 | 13.9% | 3.8% | ||
| Q2 24 | 12.6% | 5.5% |
| Q1 26 | 8.0% | — | ||
| Q4 25 | 10.3% | 7.0% | ||
| Q3 25 | 8.7% | 4.1% | ||
| Q2 25 | 9.7% | 3.2% | ||
| Q1 25 | 11.8% | 5.4% | ||
| Q4 24 | 13.6% | 2.8% | ||
| Q3 24 | 9.7% | 2.8% | ||
| Q2 24 | 8.8% | 4.2% |
| Q1 26 | $0.85 | — | ||
| Q4 25 | $1.28 | $6.91 | ||
| Q3 25 | $0.98 | $3.81 | ||
| Q2 25 | $1.06 | $2.70 | ||
| Q1 25 | $1.23 | $4.27 | ||
| Q4 24 | $1.58 | $2.21 | ||
| Q3 24 | $1.02 | $2.33 | ||
| Q2 24 | $0.93 | $3.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $4.2B |
| Total DebtLower is stronger | $10.1B | $5.7B |
| Stockholders' EquityBook value | $10.7B | $13.5B |
| Total Assets | $37.1B | $156.6B |
| Debt / EquityLower = less leverage | 0.95× | 0.42× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.5B | $4.2B | ||
| Q3 25 | $4.0B | $4.6B | ||
| Q2 25 | $3.7B | $5.4B | ||
| Q1 25 | $2.5B | $5.2B | ||
| Q4 24 | $2.9B | $3.3B | ||
| Q3 24 | $3.5B | $5.2B | ||
| Q2 24 | $2.0B | $4.6B |
| Q1 26 | $10.1B | — | ||
| Q4 25 | $10.0B | $5.7B | ||
| Q3 25 | $10.3B | $5.7B | ||
| Q2 25 | $10.3B | $5.7B | ||
| Q1 25 | $8.8B | $5.7B | ||
| Q4 24 | $9.0B | $5.0B | ||
| Q3 24 | $10.3B | $5.1B | ||
| Q2 24 | $9.2B | $5.1B |
| Q1 26 | $10.7B | — | ||
| Q4 25 | $10.4B | $13.5B | ||
| Q3 25 | $10.0B | $13.0B | ||
| Q2 25 | $9.7B | $12.1B | ||
| Q1 25 | $9.2B | $11.4B | ||
| Q4 24 | $8.4B | $10.8B | ||
| Q3 24 | $8.3B | $11.1B | ||
| Q2 24 | $7.8B | $9.7B |
| Q1 26 | $37.1B | — | ||
| Q4 25 | $36.9B | $156.6B | ||
| Q3 25 | $36.1B | $152.0B | ||
| Q2 25 | $35.5B | $133.5B | ||
| Q1 25 | $33.6B | $128.2B | ||
| Q4 24 | $33.1B | $118.7B | ||
| Q3 24 | $33.9B | $120.3B | ||
| Q2 24 | $31.9B | $109.9B |
| Q1 26 | 0.95× | — | ||
| Q4 25 | 0.96× | 0.42× | ||
| Q3 25 | 1.03× | 0.44× | ||
| Q2 25 | 1.06× | 0.48× | ||
| Q1 25 | 0.95× | 0.50× | ||
| Q4 24 | 1.06× | 0.47× | ||
| Q3 24 | 1.24× | 0.46× | ||
| Q2 24 | 1.18× | 0.52× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $7.3B |
| Free Cash FlowOCF − Capex | $112.0M | — |
| FCF MarginFCF / Revenue | 2.2% | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 15.83× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $7.3B | ||
| Q3 25 | — | $-990.0M | ||
| Q2 25 | $94.0M | $-820.0M | ||
| Q1 25 | $250.0M | $-1.4B | ||
| Q4 24 | — | $17.1B | ||
| Q3 24 | — | $-1.1B | ||
| Q2 24 | $-119.0M | $-967.0M |
| Q1 26 | $112.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $8.0M | — | ||
| Q1 25 | $98.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-183.0M | — |
| Q1 26 | 2.2% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -3.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 1.9% | — | ||
| Q2 24 | 1.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 15.83× | ||
| Q3 25 | — | -3.91× | ||
| Q2 25 | 0.19× | -4.56× | ||
| Q1 25 | 0.44× | -5.00× | ||
| Q4 24 | — | 115.81× | ||
| Q3 24 | — | -6.84× | ||
| Q2 24 | -0.28× | -4.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GEHC
| Imaging revenues | $2.3B | 45% |
| AVS revenues | $1.3B | 26% |
| PDx revenues | $770.0M | 15% |
| PCS revenues | $704.0M | 14% |
| Other revenues | $18.0M | 0% |
RGA
Segment breakdown not available.
